Wenyi Wei
Researcher Next ID · RN-022894
Researcher · Biochemistry, Genetics and Molecular Biology
Beth Israel Deaconess Medical Center
Boston, Israel
- Works count
- 444
- Citation count
- 28,283
- H-index
- 91
- i10-index
- 249
Research interests
Publications
Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade
Molecular Cell · 2021 · 10.1016/j.molcel.2021.03.037
Cancer Selective Target Degradation by Folate-Caged PROTACs
Journal of the American Chemical Society · 2021 · 10.1021/jacs.1c00451
Cell cycle on the crossroad of tumorigenesis and cancer therapy
Trends in Cell Biology · 2021 · 10.1016/j.tcb.2021.07.001
Light-induced control of protein destruction by opto-PROTAC
Science Advances · 2020 · 10.1126/sciadv.aay5154
Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer
Molecular Cancer · 2020 · 10.1186/s12943-020-01249-8
Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy
Nature Cell Biology · 2020 · 10.1038/s41556-020-0562-4
Ubiquitin signaling in cell cycle control and tumorigenesis
Cell Death and Differentiation · 2020 · 10.1038/s41418-020-00648-0
The role of ubiquitination in tumorigenesis and targeted drug discovery
Signal Transduction and Targeted Therapy · 2020 · 10.1038/s41392-020-0107-0
Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway
Science · 2019 · 10.1126/science.aau0159
Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance
Nature · 2017 · https://doi.org/10.1038/nature25015
Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4
Nature Medicine · 2017 · 10.1038/nm.4378
PtdIns(3,4,5) P 3-Dependent Activation of the mTORC2 Kinase Complex
Cancer Discovery · 2015 · 10.1158/2159-8290.cd-15-0460
Targeting Cdc20 as a novel cancer therapeutic strategy
Pharmacology & Therapeutics · 2015 · 10.1016/j.pharmthera.2015.04.002
Roles of F-box proteins in cancer
Nature reviews. Cancer · 2014 · 10.1038/nrc3700
Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus
Nature · 2014 · 10.1038/nature13079
Cancer-Associated PTEN Mutants Act in a Dominant-Negative Manner to Suppress PTEN Protein Function
Cell · 2014 · 10.1016/j.cell.2014.03.027
The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis
Cell · 2012 · 10.1016/j.cell.2012.02.065
SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
Nature · 2011 · 10.1038/nature09732
Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction
Nature Cell Biology · 2009 · 10.1038/ncb1847
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer
Cancer Cell · 2005 · 10.1016/j.ccr.2005.06.015
The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase
Cancer Cell · 2005 · 10.1016/j.ccr.2005.06.005
Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex
Nature · 2004 · 10.1038/nature02381
Role of p21 in Apoptosis and Senescence of Human Colon Cancer Cells Treated with Camptothecin
Journal of Biological Chemistry · 2002 · 10.1074/jbc.m112401200
Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization
Proceedings of the National Academy of Sciences · 1998 · 10.1073/pnas.95.25.14723
Bypass of Senescence After Disruption of p21 CIP1/WAF1 Gene in Normal Diploid Human Fibroblasts
Science · 1997 · 10.1126/science.277.5327.831
Current projects
No projects listed.